How Much Did PuraCap Pharmaceutical Raise?
Funding & Key Investors

PuraCap Pharmaceutical has solidified its market position through a significant capital injection, bringing its total funding to $150K. This recent funding amount of $150K underscores the company's robust trajectory in the competitive landscape of generic medicine and over-the-counter healthcare solutions. By securing this major strategic investment, the firm is well-positioned to accelerate its operational capacity and expand its footprint within the highly regulated pharmaceutical manufacturing sector.

What is PuraCap Pharmaceutical?

PuraCap Pharmaceutical
ManufacturingPharmaceuticals

PuraCap Pharmaceutical LLC operates as a multifaceted entity, integrating PuraCap Laboratories and Puravation Pharmaceuticals to deliver a comprehensive portfolio of prescription generics and OTC healthcare products. The organization distinguishes itself through a commitment to high-quality, affordable medication, underpinned by state-of-the-art manufacturing facilities that strictly adhere to US FDA cGMP regulatory guidelines. Their specialized focus on soft gelatin capsule production serves as a critical differentiator, allowing the company to maintain rigorous quality control while scaling production to meet the evolving demands of the global healthcare market. By bridging the gap between complex pharmaceutical development and accessible consumer health products, PuraCap has established itself as a reliable partner in the pharmaceutical supply chain.

How much funding has PuraCap Pharmaceutical raised?

PuraCap Pharmaceutical has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in PuraCap Pharmaceutical

PPP

Public-Private Partnership

What's next for PuraCap Pharmaceutical?

With the recent infusion of capital, PuraCap Pharmaceutical is poised to enter a new phase of industrial scaling and market penetration. The strategic allocation of these funds will likely prioritize the optimization of their cGMP-compliant manufacturing infrastructure, ensuring that the company remains at the forefront of soft gelatin capsule technology. As the firm navigates the complexities of the late-stage growth environment, the focus will shift toward expanding its private label offerings and strengthening its distribution networks. This financial backing provides the necessary liquidity to navigate regulatory hurdles and capitalize on emerging opportunities within the generic drug market, ultimately driving long-term value for stakeholders and improving patient access to essential healthcare solutions.

See full PuraCap Pharmaceutical company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Building MaterialsManufacturingAutomotive PartsReal Estate
ElectronicsManufacturing
ManufacturingPharmaceuticals
Household GoodsManufacturingFlowers, Gifts & Specialty StoresRetail

Frequently Asked Questions Regarding PuraCap Pharmaceutical Financial Insights

What are the most recent funding rounds that PuraCap Pharmaceutical has completed, and what were the funding rounds?
PuraCap Pharmaceutical has recently completed 1 funding rounds: Debt on May 3, 2020.
What is the total amount of funding PuraCap Pharmaceutical has raised to date?
PuraCap Pharmaceutical has raised a total of $150K in funding to date.
How many funding rounds has PuraCap Pharmaceutical completed?
PuraCap Pharmaceutical has completed 1 funding rounds.
How much funding did PuraCap Pharmaceutical raise in its most recent funding round?
PuraCap Pharmaceutical raised $150K in its most recent funding round.
Who are the lead investors in PuraCap Pharmaceutical's latest funding round?
The lead investor in PuraCap Pharmaceutical's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PuraCap Pharmaceutical's history?
The largest funding round in PuraCap Pharmaceutical's history was $150K.
See more information about PuraCap Pharmaceutical